The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 08, 2022

Filed:

Dec. 20, 2018
Applicant:

Kb Biomed Inc., Chungcheongbuk-do, KR;

Inventors:

Yong Kyu Lee, Chungcheongbuk-do, KR;

Seung Bin Cha, Gyeonggi-do, KR;

Sung Hun Kang, Chungcheongbuk-do, KR;

Sun Hwa Lee, Daejeon, KR;

Assignee:

KB BIOMED INC., Chungcheongbuk-do, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/64 (2017.01); A61K 47/54 (2017.01); A61K 9/00 (2006.01); A61K 38/17 (2006.01); A61K 38/26 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/64 (2017.08); A61K 9/0053 (2013.01); A61K 38/17 (2013.01); A61K 38/26 (2013.01); A61K 47/549 (2017.08); A61K 48/00 (2013.01);
Abstract

The present invention relates to an orally-administered gene carrier and a use thereof, and more specifically, to: an oral gene carrier comprising, at the C-terminus of an immunoglobulin Fc region, a linker formed from cationic arginine and enabling the condensation of an anionic gene; and an oral composition for preventing, ameliorating or treating metabolic diseases, the composition comprising the gene carrier and the GLP-1 gene as active ingredients. The gene carrier, according to the present invention, may be usefully employed as an orally-administered carrier for various genes, and especially, is expected to be usable for preventing, ameliorating or treating metabolic diseases, such as diabetes and obesity, by effectively transferring the GLP-1 gene.


Find Patent Forward Citations

Loading…